!!!! 𝗝𝗢𝗕 𝗠𝗔𝗥𝗞𝗘𝗧 𝗨𝗣𝗗𝗔𝗧𝗘 𝟭𝟬/𝟮𝟬/𝟮𝟱 !!!!
As of mid-October 2025, the pharmaceutical and biotech industries are on track to surpass 60,000 employees laid off in 2025 by year-end, marking one of the steepest annual workforce reductions in the life sciences sector in over a decade.
Key 2025 Layoff Trends
Biopharma Layoffs:
There have already been 128 biotech and pharma layoff rounds in the first half of 2025, a 32% jump from 2024. This pace puts the sector on track to exceed 200 layoffs total for the year, surpassing 2024’s full-year record of 192.
May 2025 alone saw 29 separate reductions-in-force, the highest monthly total on record for this industry.
Total Employees Affected:
Just six major pharmaceutical firms including Bristol Myers Squibb, Merck, Genentech, Novartis, and Pfizer, are collectively responsible for a STAGGERING nearly 39,000 job cuts so far, primarily through site consolidations, R&D restructuring, and post-patent cost savings.
Factoring in smaller biotech layoffs, analysts estimate the total employee impact could reach 60,000–65,000 by year-end 2025.
Driving Factors:
Patent cliffs (e.g. Eliquis, Opdivo, Keytruda) are forcing cost realignments.
AI integration and automation are streamlining early drug discovery and data functions, reducing human headcount.
VC funding slowdown (down ~20% year-over-year) continues to strain smaller biotechs, forcing mergers, asset sales, or shutdowns.
Focus shift to later-stage and revenue-generating assets has deprioritized early pipeline projects and associated teams.
Outlook
Analysts expect the layoff wave to persist into early 2026, fueled by further strategic realignments, continued capital constraints, and AI-driven efficiency initiatives.
The most vulnerable segments remain preclinical biotechs and mid-tier commercial organizations without late-stage or monetized portfolios.
In short, 2025 has already cemented itself as a year of historic restructuring across the life sciences workforce, layoffs surpassing even the post-2020 correction levels.
If you factor in globally located people, the number is 80,000-85,000 impacted.
NOTE: if you are on the market, there are still jobs to be had. You must remain optimistic and persistent. Tailor your job search to the jobs that fit your most recent experience the best as that is where you will shine the most. If you are going for jobs where you have experience from 5 years ago, you will be up against a slate of candidates that are CURRENTLY doing the job. You will stand-out the most with your current experience. Don’t give up. Stay positive and keep at it.